Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,493 papers from all fields of science
Search
Sign In
Create Free Account
BW 619C89
Known as:
619C89
, BW-619C89
, BW619C89
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
sipatrigine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence
J. Callaway
,
J. Callaway
,
+7 authors
B. Jarrott
Neuropharmacology
2004
Corpus ID: 23419900
Highly Cited
2001
Highly Cited
2001
The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK
H. J. Meadows
,
C. Chapman
,
+5 authors
A. Randall
Brain Research
2001
Corpus ID: 37830674
2000
2000
Inhibition of recombinant low-voltage-activated Ca2+ channels by the neuroprotective agent BW619C89 (Sipatrigine)
N. McNaughton
,
A. Hainsworth
,
P. Green
,
A. Randall
Neuropharmacology
2000
Corpus ID: 25249059
1999
1999
Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability
G. Garthwaite
,
D. A. Goodwin
,
J. Garthwaite
European Journal of Neuroscience
1999
Corpus ID: 25728767
A major transduction pathway for nitric oxide (NO) is stimulation of soluble guanylyl cyclase and the generation of cyclic GMP…
Expand
1999
1999
Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia.
K. Kawaguchi
,
D. Henshall
,
R. Simon
European Journal of Pharmacology
1999
Corpus ID: 45474998
1998
1998
On the inhibition of voltage activated calcium currents in rat cortical neurones by the neuroprotective agent 619C89
A. Stefani
,
A. H. Hainsworth
,
F. Spadoni
,
G. Bernardi
British Journal of Pharmacology
1998
Corpus ID: 2464364
1 The lamotrigine analogue 619C89, utilised to reduce postischaemic and posttraumatic neuronal injury, has been shown to inhibit…
Expand
Highly Cited
1997
Highly Cited
1997
Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat
S.E Smith
,
H. Hodges
,
+5 authors
B. S. Meldrum
Neuroscience
1997
Corpus ID: 25283858
1997
1997
Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion
K. Kawaguchi
,
S. Graham
Brain Research
1997
Corpus ID: 23119872
1997
1997
Inhibition of human N-type voltage-gated Ca2+ channels by the neuroprotective agent BW619C89
N. McNaughton
,
M. Leach
,
A. Hainsworth
,
A. Randall
Neuropharmacology
1997
Corpus ID: 41665080
1996
1996
A use-dependent sodium channel antagonist, 619C89, in reduction of ischemic brain damage and glutamate release after acute subdural hematoma in the rat.
E. Tsuchida
,
J. Harms
,
J. Woodward
,
R. Bullock
Journal of Neurosurgery
1996
Corpus ID: 21609985
Acute subdural hematoma kills or disables more severely head injured patients than any other complication of cranial trauma. The…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE